E2-CDSAlternative Names: Brain-targeted estradiol - IVAX; E2CDS; Estredox
Latest Information Update: 16 Jan 2008
At a glance
- Originator IVAX Corporation
- Class Estradiol congeners; Hormones
- Mechanism of Action Estrogen receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Alzheimer's disease; Decreased libido; Vasomotor symptoms
Most Recent Events
- 16 Jan 2007 Discontinued - Phase-II for Vasomotor symptoms in USA (PO)
- 16 Jan 2007 Discontinued - Preclinical for Decreased libido in USA (unspecified route)
- 16 Jan 2007 Discontinued - Preclinical for Alzheimer's disease in USA (unspecified route)